Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media.
van Dyk
J C
JC
Roussel Laboratories (Pty) Ltd. Johannesburg, Republic of South Africa.
Terespolsky
S A
SA
Meyer
C S
CS
van Niekerk
C H
CH
Klugman
K P
KP
D000208:Acute Disease; D000284:Administration, Oral; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002511:Cephalosporins / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004432:Ear, Middle / Q000378:metabolism; D006801:Humans; D007223:Infant; D008826:Microbial Sensitivity Tests; D010034:Otitis Media with Effusion / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D000097623:Cefpodoxime
D015296:Ceftizoxime; D002511:Cephalosporins; D000097623:Cefpodoxime